Erweiterte Informationen für Ärzte


Kotecha R et al.                               
Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT).
Front Oncol. 2021;11:760078. Published 2021 Sep 3. doi:10.3389/fonc.2021.760078

Rodríguez Plá M et al.                   
Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-Cell Lung Cancer and Melanoma: A Systematic Review.
Int J Mol Sci. 2021;22(21):11621. Published 2021 Oct 27. doi:10.3390/ijms222111621

Billing DL et al.                                 
Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.
Cancers (Basel). 2021;13(22):5773. Published 2021 Nov 18. doi:10.3390/cancers13225773

Sogono P et al.                                
Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases.                                                                                                                           Int J Radiat Oncol Biol Phys. 2021;109(3):756-763. doi:10.1016/j.ijrobp.2020.10.011

Virbel G et al.                                   
Stereotactic Body Radiotherapy for Patients with Lung Oligometastatic Disease: A Five-Year Systematic Review.
Cancers (Basel). 2021;13(14):3623. Published 2021 Jul 20. doi:10.3390/cancers13143623

Méndez Romero A et al.              
Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1377-1386. doi: 10.1016/j.ijrobp.2020.11.045. Epub 2021 Jan 12. PMID: 33451857.

Ehret F et al.     
Image-Guided Robotic Radiosurgery for the Management of Intramedullary Spinal Cord Metastases-A Multicenter Experience.
Cancers (Basel). 2021;13(2):297. Published 2021 Jan 15. doi:10.3390/cancers13020297

Burkon P et al.                 
Stereotactic Body Radiotherapy for Lymph Node Oligometastases: Real-World Evidence From 90 Consecutive Patients.
Front Oncol. 2021;10:616494. Published 2021 Feb 5. doi:10.3389/fonc.2020.616494

Dohopolski M et al.        
Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy.
Ann Palliat Med. 2021 Feb 23:apm-20-1409. doi: 10.21037/apm-20-1409. Epub ahead of print. PMID: 33691460.

Rogowski P et al.             
Radiotherapy of oligometastatic prostate cancer: a systematic review.
Radiat Oncol. 2021;16(1):50. Published 2021 Mar 9. doi:10.1186/s13014-021-01776-8

Pepin A et al.                    
Impact of Age on Patient-Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer.
Cureus. 2021;13(3):e13780. Published 2021 Mar 9. doi:10.7759/cureus.13780

Vlaskou B et al.                
Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research.
Transl Lung Cancer Res. 2021;10(4):1930-1949. doi:10.21037/tlcr-20-860

Kinj R et al.                        
Stereotactic lung reirradiation for local relapse: A case series.
Clin Transl Radiat Oncol. 2021;28:85-87. Published 2021 Apr 5. doi:10.1016/j.ctro.2021.03.007

Long Y et al.                      
Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Radiat Oncol. 2021;16(1):68. Published 2021 Apr 8. doi:10.1186/s13014-021-01761-1

Wolf F et al.                      
Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.
Strahlenther Onkol. 2021 Feb;197(2):89-96. doi: 10.1007/s00066-020-01723-8. Epub 2020 Dec 10. PMID: 33301049; PMCID: PMC7726607.